Summit Securities Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,500
Closed -$22.8K 1034
2025
Q3
$22.8K Buy
+4,500
New +$19.9K ﹤0.01% 743

Other funds holding SRTA

Summit Securities Group's SRTA Position: Q3 2025 in Review

Summit Securities Group sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 1,047 shares — an estimated $4.63K sold.

Summit Securities Group first reported a position in SRTA in Q2 2025 and held it in 1 quarter. The position peaked at $4.22K in Q2 2025. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • Summit Securities Group reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • Summit Securities Group sold 1,047 Strata Critical Medical Inc shares in Q3 2025, an estimated $4.63K.
  • Summit Securities Group first reported a position in Strata Critical Medical Inc in Q2 2025 and held it in 1 quarter.
  • Summit Securities Group's Strata Critical Medical Inc position peaked at $4.22K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.